Nexaph
Finnrick has tested 216 samples from Nexaph across 9 products.
Finnrick Vendor Profile
to
Nexaph
Tracking 9 products
216 total samples tested
Last test 23 Apr 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Cagrilintide | 11 | 14 Jun 2025 | 18 Mar 2026 | |||||
| CJC-1295 | 6 | 10 Jun 2025 | 6 Nov 2025 | |||||
| GHK-Cu | 5 | 4 Aug 2025 | 2 Feb 2026 | |||||
| Semaglutide | 15 | 11 Jun 2025 | 6 Mar 2026 | |||||
| BPC-157 | 14 | 29 Jun 2025 | 23 Apr 2026 | |||||
| Ipamorelin | 9 | 3 Jul 2025 | 16 Feb 2026 | |||||
| Retatrutide | 86 | 11 Jun 2025 | 23 Apr 2026 | |||||
| Tesamorelin | 23 | 29 Jun 2025 | 25 Mar 2026 | |||||
| Tirzepatide | 47 | 2 Jul 2025 | 25 Mar 2026 | |||||
The Nexaph samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.7
Based on 30 overall satisfaction reports
Ease of Purchase5.0(30)
Payment Methods4.9(29)
Delivery Speed4.9(29)
Packaging Quality4.7(29)
Customer Service4.3(9)
People who submitted test requests to Finnrick gave Nexaph an average satisfaction rating of 4.7 out of 5 across 30 reports associated with samples received and tested by Finnrick.
Most recent Nexaph tests
Samples are tested in commercial labs
216
tests
9
products
Scores
AVGMINMAX
First
10 Jun 2025
Last
23 Apr 2026
| Quantity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 23 Apr 2026 | BPC-157 | View | 10mg | (no batch claim) | 11.6mg | +16.0% | 98.90% | below LOQ | BPC1003112026-21 | White Label / Red Crimp / Clear Blue Cap | Lab E | Public | |
| 23 Apr 2026 | Retatrutide | View | 24mg | 28.1mg | 25.5mg | -9.4% | 99.90% | below LOQ | NXP-3P2401262026-13 | White Label / Black Crimp / Purple Cap | Lab E | Public | |
| 25 Mar 2026 | Tesamorelin | View | 10mg | ⚠️ Sample does not contain Tesamorelin | n/a | TES1003052026-18 | No Label / Green Crimp / Violet Cap | Lab G | Public | ||||
| 25 Mar 2026 | Tirzepatide | View | 60mg | (no batch claim) | 72.9mg | +21.5% | 99.90% | n/a | Nxp-2p6001152026-01 | No Label / Red Crimp / Green Cap | Lab G | Public | |
| 18 Mar 2026 | Tesamorelin | View | 10mg | 11.2mg | 11mg | -1.9% | 99.40% | n/a | TES1011262025-14 | White Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 18 Mar 2026 | Cagrilintide | View | 5mg | 6.1mg | 5.35mg | -12.0% | 96.90% | n/a | CAG0512302025-10 | No Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 18 Mar 2026 | BPC-157 | View | 10mg | (no batch claim) | 10.6mg | +6.0% | 99.90% | n/a | BPC1002252026-20 | No Label / Black Crimp / White Cap | Lab E | Public | |